The CME will help blood bank personnel to effectively report data in transfusion reaction reporting form (TRRF) as a part of Haemovigilance Programme of India (HvPI) for blood safety. Blood transfusion related data in TRRF from various centres is being collected through a software, Haemo-Vigil, indigenously developed by IT division of NIB.
This comes close on the heels of Drug Controller General of India (DCGI) asking the state drug controllers (DCs) to direct all licensed blood banks for uplinking transfusion adverse reactions with NIB under the HvPI. There are in total 2760 licensed blood banks in the country which will be covered under the programme.
Launched on December 10, 2012 by NIB, HvPI covers blood banks, medical colleges, government and private hospitals across the country.
The role of HvPI is to help identifying trends in adverse reactions and events, thereby to also form transfusion policy through a transparent reporting system. The reporting system deployed under HvPI is confidential, systems oriented and responsive. The identities of the patient, reporter and institution are never revealed to third party going by the clause for confidentiality. It is therefore independent of any authority.
This will help health ministry to take safety related regulatory decisions in blood safety. HvPI role is also to ensure that traceability of events is done through proper documentation. This will lead to effective recommendations to be accepted and acted upon as also through defining systematic documentation process.
NIB and Indian Pharmacopoeia Commission (IPC) are the co-ordinating centres between the reporters and regulators. NIB is an autonomous institution under the Union health ministry which ensures quality of biologicals and vaccines in the country available through domestic manufacturers or imports.
Pharm.D @ SRIPMS-CBE-TN